2017
DOI: 10.1016/j.psychres.2017.06.069
|View full text |Cite
|
Sign up to set email alerts
|

A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia

Abstract: To assess the long-term effectiveness of antipsychotic medications in facilitating work functioning in patients with schizophrenia we conducted longitudinal multi followup research on 139 initially psychotic patients. The 70 patients with schizophrenia and 69 initially psychotic mood disordered control patients were followed up 6 times over 20 years. We compared the influence on work functioning of patients with schizophrenia continuously prescribed antipsychotics with patients with schizophrenia not prescribe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
35
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 54 publications
(38 citation statements)
references
References 61 publications
2
35
0
1
Order By: Relevance
“…However, recovery rates were twice as likely in the initial dose‐reduction group (40.4% vs. 17.6%, p=0.004), driven not by symptomatic remission (69.2% vs. 66.7%, p=0.79), but by functional remission (46.2% vs. 19.6%, p=0.01), and 8 of the 11 patients off antipsychotics for 2 years were in the original dose‐reduction condition. These results have been cited as important evidence that antipsychotics could postpone rather than prevent relapse, while impacting negatively on functional recovery in the long‐term.…”
Section: Efficacy Effectiveness and Tolerabilitymentioning
confidence: 99%
See 2 more Smart Citations
“…However, recovery rates were twice as likely in the initial dose‐reduction group (40.4% vs. 17.6%, p=0.004), driven not by symptomatic remission (69.2% vs. 66.7%, p=0.79), but by functional remission (46.2% vs. 19.6%, p=0.01), and 8 of the 11 patients off antipsychotics for 2 years were in the original dose‐reduction condition. These results have been cited as important evidence that antipsychotics could postpone rather than prevent relapse, while impacting negatively on functional recovery in the long‐term.…”
Section: Efficacy Effectiveness and Tolerabilitymentioning
confidence: 99%
“…Most, but not all, of the studies with follow‐up >3 years reported worse outcomes associated with continued antipsychotic use. However, these results are inconclusive, given small and selective patient samples and extensive risk of bias. Conversely, long‐term register studies of much larger and representative national cohorts of patients diagnosed with schizophrenia confirmed significantly less treatment failure and suicide‐related mortality in antipsychotic‐treated patients compared to those not treated with antipsychotics.…”
Section: Efficacy Effectiveness and Tolerabilitymentioning
confidence: 99%
See 1 more Smart Citation
“…We also compared a good‐prognosis sample of patients prescribed antipsychotics for 15‐20 years with a good‐prognosis sample of patients not prescribed antipsychotics for 15‐20 years. In both comparisons, those patients not on antipsychotics for 15‐20 years had fewer symptoms and better outcomes after the first 2‐3 years.…”
mentioning
confidence: 97%
“…These studies have been conducted by eight different investigator groups. They include those by Wunderink et al in the Netherlands, our own Chicago Followup Study, the Suffolk County study of Kotov et al in the US, and the long‐term data provided by the Danish OPUS trial, the AESOP‐10 study in England, the Finnish Birth Cohort Study, the Alberta Hospital Follow‐Up Study in Western Canada, and the international follow‐up study by Harrison et al. These research programs included samples studied from 7 to 20 years.…”
mentioning
confidence: 99%